These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 18064767

  • 21. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 May 09; 67(90):31125-7. PubMed ID: 12001972
    [Abstract] [Full Text] [Related]

  • 22. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug 29; 65(168):52302-5. PubMed ID: 11067736
    [Abstract] [Full Text] [Related]

  • 23. Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Mar 06; 72(43):9849-52. PubMed ID: 17447341
    [Abstract] [Full Text] [Related]

  • 24. Skin protectant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Jun 04; 68(107):33362-81. PubMed ID: 12785379
    [Abstract] [Full Text] [Related]

  • 25. Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products; technical amendments. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule; technical amendments.
    Fed Regist; 1999 Sep 14; 64(177):49652-5. PubMed ID: 10915461
    [Abstract] [Full Text] [Related]

  • 26. Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Apr 17; 68(74):18869-82. PubMed ID: 12701600
    [Abstract] [Full Text] [Related]

  • 27. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use; delay of compliance dates. Final rule; delay of compliance dates; request for comments.
    Food and Drug Administration, HHS.
    Fed Regist; 2012 May 11; 77(92):27591-3. PubMed ID: 22606729
    [Abstract] [Full Text] [Related]

  • 28. Ingrown toenail relief drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 May 07; 68(88):24347-9. PubMed ID: 12737160
    [Abstract] [Full Text] [Related]

  • 29. Drug labeling; orally ingested over-the-counter drug products containing calcium, magnesium, and potassium. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2004 Mar 24; 69(57):13725-35. PubMed ID: 15040351
    [Abstract] [Full Text] [Related]

  • 30. Anorectal drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Aug 26; 68(165):51167-70. PubMed ID: 12952012
    [Abstract] [Full Text] [Related]

  • 31. Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye's Syndrome warning. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Apr 17; 68(74):18861-9. PubMed ID: 12701599
    [Abstract] [Full Text] [Related]

  • 32. Laxative drug products for over-the-counter human use; psyllium ingredients in granular dosage forms. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Mar 29; 72(60):14669-74. PubMed ID: 17450664
    [Abstract] [Full Text] [Related]

  • 33. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar 17; 64(51):13254-303. PubMed ID: 10557606
    [Abstract] [Full Text] [Related]

  • 34. Child-resistant packaging for certain over-the-counter drug products. Final rule.
    Consumer Product Safety Commission.
    Fed Regist; 2001 Aug 02; 66(149):40111-6. PubMed ID: 11732555
    [Abstract] [Full Text] [Related]

  • 35. Ophthalmic drug products for over-the-counter human use; proposed amendment of final monograph--FDA. Proposed rule.
    Fed Regist; 1998 Feb 23; 63(35):8888-90. PubMed ID: 10177740
    [Abstract] [Full Text] [Related]

  • 36. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2009 Apr 29; 74(81):19385-409. PubMed ID: 19507324
    [Abstract] [Full Text] [Related]

  • 37. Over-the-counter vaginal contraceptive and spermicide drug products containing nonoxynol 9; required labeling. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Dec 19; 72(243):71769-85. PubMed ID: 18159651
    [Abstract] [Full Text] [Related]

  • 38. Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Jan 29; 64(19):4535-40. PubMed ID: 10557608
    [Abstract] [Full Text] [Related]

  • 39. Status of certain additional over-the-counter drug category II and III active ingredients--FDA. Final rule.
    Fed Regist; 1998 Apr 22; 63(77):19799-802. PubMed ID: 10179316
    [Abstract] [Full Text] [Related]

  • 40. Over-the-counter drug products containing analgesic/antipyretic active ingredients for internal use; required alcohol warning; final rule; compliance date. Food and Drug Administration, HHS.
    Fed Regist; 1999 Mar 17; 64(51):13066-7. PubMed ID: 10557605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.